The Week in Review: ShangPharma Receives Go-Private Offer from Chairman
The Chairman of ShangPharma and TPG Capital have offered to take the company private at a price of between $8.50 and $9.50 per ADS; ScinoPharm, a Taiwan CMO/CRO, will spend $37.6 million to build a chemotherapy manufacturing plant in Tainan Science Park; Karl Storz, a German medical device maker, started construction of its $31.5 million China headquarters in Shanghai; Beijing is testing the zero-markup policy for hospital pharmacies at Beijing Friendship Hospital; the SEC halted trading in China Medical Technologies, a diagnostics company, pending an investigation of the companies finances. More details…. Stock Symbols: (NYSE: SHP) (TWSE: 1789) (OTCBB: CMEDY) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here